findmyKOL
Clinical trialNCT05197270RecruitingPhase 1/PHASE2Interventional

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Sponsor4D Molecular TherapeuticsEnrollment215Neovascular (Wet) Age-Related Macular Degeneration
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • Emanuelli Research and Development Center, Llc

    Arecibo, Puerto Rico, Puerto Rico

    Andres Emanuelli, MD
    Recruiting
United States
  • Barnet Delaney Perkins Eye Center

    Phoenix, Arizona, United States

    Suhail Alam, M.D.
    Recruiting
  • California Retina Consultants

    Oxnard, California, United States

    Dante Pieramici, M.D.
    Recruiting
  • Retinal Consultants Medical Group

    Sacramento, California, United States

    Joel Pearlman, M.D., Ph.D.
    Recruiting
  • Colorado Retina Associates

    Lakewood, Colorado, United States

    Murtaza Adam, MD
    Recruiting
  • Rand Eye Institute

    Deerfield Beach, Florida, United States

    Suspended
  • Retina Vitreous Consultants, Llp Dba Retina Group of Florida

    Fort Lauderdale, Florida, United States

    Active, not recruiting
  • Vitreo Retinal Associates

    Gainesville, Florida, United States

    Christine Kay, M.D.
    Recruiting
  • Florida Eye Associates

    Melbourne, Florida, United States

    Vrinda Hershberger, M.D., Ph.D.
    Recruiting
  • Retinal Specialty Institute

    Pensacola, Florida, United States

    Sunil Gupta, M.D.
    Recruiting
  • Retina Vitreous Associates of Florida

    Tampa, Florida, United States

    David Eichenbaum, M.D.
    Recruiting
  • University Retina and Macula Associates

    Oak Forest, Illinois, United States

    Veeral Sheth, M.D.
    Recruiting
  • Retina Partners Midwest

    Carmel, Indiana, United States

    Raj Maturi, MD
    Recruiting
  • Cumberland Valley Retina Consultants

    Hagerstown, Maryland, United States

    Allen Hu, M.D.
    Recruiting
  • Ophthalmic Consultants of Boston & Boston Eye Surgery and Laser Center

    Boston, Massachusetts, United States

    Jeffrey Heier, MD
    Recruiting
  • Sierra Eye Associates

    Reno, Nevada, United States

    Arshad Khanani, M.D., M.A.
    Recruiting
  • Western Carolina Retinal Associates

    Asheville, North Carolina, United States

    Withdrawn
  • Verum Research, Llc

    Eugene, Oregon, United States

    Albert Edwards, MD
    Recruiting
  • Mid Atlantic Retina

    Bethlehem, Pennsylvania, United States

    Ajay Kuriyan, MD
    Recruiting
  • Palmetto Retina Center, Llc

    West Columbia, South Carolina, United States

    John Wells, MD
    Recruiting
  • Tennessee Retina

    Nashville, Tennessee, United States

    Carl Awh, MD
    Recruiting
  • Austin Clinical Research

    Austin, Texas, United States

    Fuad Makkouk, M.D.
    Recruiting
  • Valley Retina Institute, Pa

    McAllen, Texas, United States

    Victor Gonzalez, M.D.
    Recruiting
  • Retina Consultants of Texas

    The Woodlands, Texas, United States

    Withdrawn
  • Pacific Northwest Retina Llc

    Bellevue, Washington, United States

    Withdrawn

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Dec 2021
Primary completion
31 Mar 2027
Completion
31 Jan 2031
Last update posted
12 Feb 2026
Registered enrollment
215
Registry id
NCT05197270

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.